Finance

Lists
INCR:NASDAQ
InterCure Ltd
4,72 US$
+0,32%
(+0,015) 1D
15 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCR...
Open
4,81 US$
High
4,94 US$
Low
4,65 US$
Mkt. cap
225,85 მლნ.
Avg. vol.
6,03 ათ.
Volume
0,00
52-wk high
8,10 US$
52-wk low
3,40 US$
Beta
1,43
Shares outstanding
11,85 მლნ.
No. of employees
285
Open
4,81 US$
High
4,94 US$
Low
4,65 US$
Mkt. cap
225,85 მლნ.
Avg. vol.
6,03 ათ.
Volume
0,00
52-wk high
8,10 US$
52-wk low
3,40 US$
Beta
1,43
Shares outstanding
11,85 მლნ.
No. of employees
285
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
1 საათის წინ
Iambic Therapeutics raises USD 150m in Nasdaq IPO
The Globe and Mail
The Globe and Mail
·
41 წუთის წინ
TNL Mediagene Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance
Yahoo Finance
·
26 წუთის წინ
What iShares Core S&P 500 ETF (IVV) Bought: NVIDIA Leads on Oct. 14
Seeking Alpha
Seeking Alpha
·
46 წუთის წინ
Dow Jones Bullish Catch-Up Over Nasdaq 100 As AI Rotation Accelerates
About InterCure Ltd
CEOალექსანდერ რაბინოვიჩი
Employees285
Founded1994
Headquarters-
SectorPharmaceutical industry
Websiteintercure.co
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in ILS
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
65,01 მლნ.
65,01 მლნ.
70,09 მლნ.
70,09 მლნ.
Cost of goods sold
44,89 მლნ.
44,89 მლნ.
69,86 მლნ.
69,86 მლნ.
Cost of revenue
44,89 მლნ.
44,89 მლნ.
69,86 მლნ.
69,86 მლნ.
Research and development expenses
95,50 ათ.
95,50 ათ.
99,50 ათ.
99,50 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,21 მლნ.
20,21 მლნ.
26,49 მლნ.
26,49 მლნ.
Operating expense
17,21 მლნ.
17,21 მლნ.
36,76 მლნ.
36,76 მლნ.
Total operating expenses
62,11 მლნ.
62,11 მლნ.
106,61 მლნ.
106,61 მლნ.
Operating income
2,90 მლნ.
2,90 მლნ.
-36,52 მლნ.
-36,52 მლნ.
Other non operating income
-
-
-85,50 ათ.
-85,50 ათ.
EBT including unusual items
-1,15 მლნ.
-1,15 მლნ.
-20,90 მლნ.
-20,90 მლნ.
EBT excluding unusual items
-1,11 მლნ.
-1,11 მლნ.
-40,80 მლნ.
-40,80 მლნ.
Income tax expense
-242,50 ათ.
-242,50 ათ.
-3,42 მლნ.
-3,42 მლნ.
Effective tax rate
21,11%
21,11%
16,35%
16,35%
Other operating expenses
-3,53 მლნ.
-3,53 მლნ.
9,40 მლნ.
9,40 მლნ.
Net income
-852,00 ათ.
-852,00 ათ.
-17,00 მლნ.
-17,00 მლნ.
Net profit margin
-1,31%
-1,31%
-24,26%
-24,26%
Earnings per share
-
-
-
-
Interest and investment income
1,18 მლნ.
1,18 მლნ.
-
-
Interest expense
-5,18 მლნ.
-5,18 მლნ.
-5,05 მლნ.
-5,05 მლნ.
Net interest expenses
-4,01 მლნ.
-4,01 მლნ.
-5,05 მლნ.
-5,05 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,12 მლნ.
7,12 მლნ.
-34,80 მლნ.
-34,80 მლნ.
Gain or loss from assets sale
-
-
1,63 მლნ.
1,63 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები